SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : VD's Model Portfolio & Discussion Thread

 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: Vector1 who wrote (4608)4/15/1998 3:12:00 PM
From: biowa  Read Replies (2) of 9719
 
V1,

Wednesday April 15, 5:59 am Eastern Time

Company Press Release

SOURCE: VD's Model Portfolio, LLC

VD's Model Portfolio Scientific Adviser Under Investigation for Insider Activity

Fort Dodge, Iowa, April 15 /PRNewswire/ -- VD's Model Portfolio, LLC. (SI: VDXXX - news) today announced that one of its scientific advisers is under investigation by the Silicon Investors Commission (SIC). biowa, who also has been acting as VDXXX's Senior Director of Regulatory Affairs and Really Long Legal Documents, has been questioned by the SIC in regard to alleged insider posting activities in the days leading up to the FTA's surprise provisional approval of VDXXX's discussion thread.

V1, Chair and one of VDXXX's co-founders, commented, "biowa has been with VDXXX since the beginning and I know him almost as well as Andy knows the management over at CYTO; I am very confident that there is nothing to this. The SIC is concerned because in the days leading up to the announcement, biowa's posting activity increased tremendously over the level of several weeks earlier. I expect this to be resolved quickly, however, as soon as the SIC verifies that in fact his earlier vanishing act was an anomaly resulting from his temporary hiatus at one of this country's finest facilities for those who can't take the stress of investing in the biotech sector."

The unexpected approval by the FTA caught many VDXXX investors by surprise. Analysts had earlier expected the FTA to ask VDXXX to conduct further clinical and pre-clinical trials, including a rat model to see if rodents crawling on a keyboard couldn't reproduce most of the thread's postings. This was expected to lead to huge profits for Genzyme Transgenics (Nasdaq: GZTC - News) VDXXX's favorite contract research organization (CRO). This view was further bolstered by last month's 7-2 vote by an FTA advisory committee recommending against approval. That recommendation, however, was widely criticized by members of the Hawaii General Assembly because the advisory panel was primarily made up of Y2K fanatics. In addition, Rocketman, another VDXXX co-founder threatened to add all FTA employees to his humor e-mail list, an act which combined with the current effort to review the Henry Niman Ligand thread threatened to bring FTA operations to a complete halt.

biowa was unavailable for comment as he was frantically trying to find tax losses to offset the large capital gains he made on Alpha-Beta Technology (Nasdaq: ABTI - News) and Matrix Pharmaceuticals (Nasdaq: MATX - News). He also was reportedly leading efforts to locate and raise the legendary Greyfish, lost at sea during the past year.

HAPPY TAX DAY to all,
biowa
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext